Lv744
3760 积分 2025-02-12 加入
Orthogonal Conjugation via Endoglycosidase and Microbial Transglutaminase Enables Efficient Synthesis of Dual-Payload Antibody-Drug Conjugates
2天前
已完结
Predicting Tumor Volume Doubling Time and Progression-Free Survival in Untreated Patients from Patient-Derived-Xenograft (PDX) Models: A Translational Model-Based Approach
8天前
已完结
Functional Analysis of the PI3K/AKT/mTOR Pathway Inhibitor, Gedatolisib, Plus Fulvestrant with and Without Palbociclib in Breast Cancer Models
8天前
已完结
Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor
8天前
已完结
Broadening the Therapeutic Window of ADCs Using Site-Specific Bioconjugation Showcased by an MMAE-Containing Peptide Linker in a CD79b-Targeting ADC
13天前
已完结
Multivalent linkers: A growing trend in antibody–drug conjugate development
22天前
已完结
An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody–Drug Conjugates
2个月前
已完结
Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis
2个月前
已完结
Recent Advances in Peptide Linkers of Antibody–Drug Conjugates
2个月前
已完结
Design of cathepsin-sensitive linkers for tumor-selective bioconjugate drug delivery
2个月前
已完结
皖公网安备34019202002308
